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Introduction 
The exact molecular mechanism of second lineage segregation of the inner cell mass (ICM) 
into epiblast and hypoblast remains largely unknown. Recently, it has been shown that 
inhibition of the Mitogen-Activated Protein Kinase (MAPK) and Glycogen Synthase Kinase 
(GSK)3β during mouse embryonic development prevents hypoblast formation. A possible 
alternative pathway of interest is the Transforming Growth Factor (TGF)β pathway, which 
has been shown to regulate Nanog expression in embryonic stem cells. It remains to be 
investigated whether TGFβ is also involved in the second lineage segregation in both mouse 
and human. Hence we verified the effect of TGFβ signalling activation and inhibition on the 
allocation of the ICM towards epiblast and hypoblast during mouse and human embryonic 
development.  
 
Materials and Methods 
All patients donating research embryos for this project provided written informed consent.  
This study was approved by the local Ethical Committee (2009/281) and the Federal Ethical 
Committee for embryo research (Adv-030).  For this experiment, 134 donated fresh day 3 
spare human embryos were used. These fresh embryos did not meet the IVF laboratory 
criteria for transfer or cryopreservation and were randomized into three different culture 
groups (i): Control Cook Blastocyst medium (CB), (ii): CB+SB431542 (TGFβ inhibitor; 
10µM), (iii): CB+Activin A (TGFβ activator; 50 ng/mL). In parallel, 107 B6D2F1 
reconstructed parthenogenetic mouse 2-cell embryos were randomized into these groups as 
well, using sequential KSOM/CB medium. Both human and mouse embryos were cultured at 
37°C, 6% CO2 and 5% O2. Blastocysts were scored at day 5 and 6, for mouse and human 
respectively, and fixed using 4% paraformaldehyde. Immunocytochemistry was performed for 
Nanog (epiblast marker) and Gata (Gata6 in human, Gata4 in mice; hypoblast markers). 
Blastocyst formation rates were analysed by contingency table analysis followed by Chi-
square or Fisher’s exact tests. P-values of ≤ 0.05 were considered to be significant. Parameters 
of ICM allocation were compared using one-way analysis of variance (ANOVA) followed by 
Tukey post-test when the significance level reached P<0.05. 
 
Results 
In mice, embryos developed into blastocysts at similar rates in the different treatment groups 
(92, 90 and 90% resp.). Immunostaining revealed significantly higher numbers of Nanog 
(12.6 ± 4.8 versus 8.3 ± 3.0; P<0.001) and lower numbers of Gata+ cells (7.5 ± 3.8 versus 10.1 
± 2.7 resp.; P<0.05) in the SB431542 group compared to the control. Activin A treated 
blastocysts showed significantly lower numbers of Gata+ cells in their ICMs compared to the 
control (5.5 ± 2.3 versus 10.1 ± 2.7 resp.; P<0.01), while the number of Nanog+ cells 
remained similar to the control (6.4 ± 1.9 versus 8.3 ± 3.0). In human, blastocyst development 
was also comparable between the groups (29, 31 and 27% resp.), while the number of Nanog+ 
cells tended to be higher in the SB431542 group compared to the control (11.0 ± 7.2 versus 
5.7 ± 4.4), but not in the Activin A group (6.7 ± 3.7). There were no differences in Gata+ cells 
between the groups (8.6 ± 3.2, 8.0 ± 4.6 and 9.2 ± 5.1 resp.). 
 
Conclusions 
In mice, inhibition of TGFβ signalling by SB431542 resulted in ICMs with more Nanog+ and 
less Gata+ cells. Activation of the pathway reduced the number of Gata+ cells as well, but the 
number of Nanog+ cells remained the same. In human, the number of Nanog+ ICM cells 
seemed to increase after TGFβ inhibition as well. Therefore, we can conclude that the TGFβ 
pathway plays an active role during early lineage segregation, which could affect stem cell 
derivation efficiency. 
